Amirayan N, Vernet C, Machy P
Centre d'Immunologie INSERM-CNRS de Marseille-Luminy, France.
J Immunol. 1992 Apr 1;148(7):1971-8.
Murine T and B splenocytes were incubated with antibodies that recognize CD3 or surface IgM. These antibodies induced proliferation of their respective target cells. Once stimulated via their receptors, the proliferation of both CD4+ and CD8+ T but not B lymphocytes was inhibited by class I-specific antibodies or their monovalent Fab' fragments. The inhibition of proliferation was dependent on the site on class I molecules recognized by the antibodies used, with the alpha 1/alpha 2 domains of H-2K molecules representing the major site for inhibition. Only soluble antibody-mediated proliferation could be inhibited by class I-directed antibodies; proliferation induced by CD3-specific antibody immobilized on plastic was not inhibited. Primary allogeneic MLR was also inhibited by class I-specific antibodies. In contrast, neither secondary allogeneic MLR, secondary Ag-specific responses, nor proliferation of CTL clones or tumor cell lines were inhibited by class I-specific antibodies. These results suggest a role for class I molecules in regulation of TCR/CD3- but not surface IgM-mediated cell signaling, which depends on the form of stimulation and the stage of differentiation of T cells.
将小鼠T和B脾细胞与识别CD3或表面IgM的抗体一起孵育。这些抗体诱导各自靶细胞的增殖。一旦通过其受体受到刺激,I类特异性抗体或其单价Fab'片段可抑制CD4 +和CD8 + T淋巴细胞而非B淋巴细胞的增殖。增殖的抑制取决于所用抗体识别的I类分子上的位点,H-2K分子的α1 /α2结构域是主要的抑制位点。只有可溶性抗体介导的增殖可被I类导向抗体抑制;固定在塑料上的CD3特异性抗体诱导的增殖未被抑制。I类特异性抗体也可抑制初次同种异体混合淋巴细胞反应(MLR)。相比之下,I类特异性抗体既不抑制二次同种异体MLR、二次抗原特异性反应,也不抑制CTL克隆或肿瘤细胞系的增殖。这些结果表明I类分子在调节TCR / CD3介导而非表面IgM介导的细胞信号传导中起作用,这取决于刺激形式和T细胞的分化阶段。